1. Home
  2. SDRL vs CPRX Comparison

SDRL vs CPRX Comparison

Compare SDRL & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$45.29

Market Cap

2.7B

Sector

Energy

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$23.46

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
CPRX
Founded
2005
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.9B
IPO Year
2018
2006

Fundamental Metrics

Financial Performance
Metric
SDRL
CPRX
Price
$45.29
$23.46
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$51.75
$35.00
AVG Volume (30 Days)
727.1K
1.0M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
54.61
28.24
EPS
N/A
1.68
Revenue
$1,437,000,000.00
$119,072,803.00
Revenue This Year
$4.57
$9.20
Revenue Next Year
$14.36
$10.51
P/E Ratio
N/A
$14.42
Revenue Growth
3.75
16.39
52 Week Low
$18.60
$19.05
52 Week High
$46.20
$26.56

Technical Indicators

Market Signals
Indicator
SDRL
CPRX
Relative Strength Index (RSI) 59.80 47.92
Support Level $41.63 $23.27
Resistance Level N/A $24.94
Average True Range (ATR) 1.66 0.65
MACD 0.02 0.04
Stochastic Oscillator 80.76 39.14

Price Performance

Historical Comparison
SDRL
CPRX

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, Canada and others. The company derives maximum revenue from the United States.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: